New 52 Week High Today

Moderna Inc MRNA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/23/21 EDT
348.90quote price arrow up+0.07 (+0.02%)
Volume
132,394
Close
348.83quote price arrow up+25.35 (+7.84%)
Volume
22,938,048
52 week range
54.21 - 349.45

...

Loading . . .
  • Open330.90
  • Day High349.45
  • Day Low325.17
  • Prev Close323.48
  • 52 Week High349.45
  • 52 Week High Date07/23/21
  • 52 Week Low54.21
  • 52 Week Low Date09/08/20

Key Stats

  • Market Cap140.066B
  • Shares Out401.53M
  • 10 Day Average Volume28.84M
  • Dividend-
  • Dividend Yield-
  • Beta1.5
  • YTD % Change233.9

KEY STATS

  • Open330.90
  • Day High349.45
  • Day Low325.17
  • Prev Close323.48
  • 52 Week High349.45
  • 52 Week High Date07/23/21
  • 52 Week Low54.21
  • 52 Week Low Date09/08/20
  • Market Cap140.066B
  • Shares Out401.53M
  • 10 Day Average Volume28.84M
  • Dividend-
  • Dividend Yield-
  • Beta1.5
  • YTD % Change233.9

RATIOS/PROFITABILITY

  • EPS (TTM)1.25
  • P/E (TTM)278.13
  • Fwd P/E (NTM)11.70
  • EBITDA (MRQ)672.52M
  • ROE (MRQ)21.84%
  • Revenue (MRQ)2.732B
  • Gross Margin (MRQ)84.44%
  • Net Margin (MRQ)21.89%
  • Debt To Equity (MRQ)4.77%

EVENTS

  • Earnings Date08/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO1:1801:18
Johnson & Johnson vaccine much less effective against delta variant, new study says

Profile

MORE
Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced...
Noubar Afeyan Ph.D.
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
495.51+8.99+1.85%
BNTX
BioNTech SE
281.96+0.98+0.35%
GMAB
Genmab A/S
44.85+0.49+1.10%
INCY
Incyte Corp
79.30+0.68+0.86%
CRL
Charles River Laboratories International Inc
396.32+3.07+0.78%